Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03377517 · ClinicalTrials.gov registry record · NA

Radiosurgical Hypophysectomy for Bone Metasteses Pain

A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT03377517 is a NA study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03377517, a NA study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

This research is being done to see if a delivery of a single high dose of radiation therapy to a small area of the pituitary gland and pituitary stalk in a highly precise manner may be helpful in reducing intractable pain from bone metastases.

Interventions

  • RADIATION radiosurgical hypophysectomy

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-05-08
Est. Completion 2024-05-15
Phase NA

What the Registry Record Tells You About NCT03377517

The ClinicalTrials.gov registry entry for NCT03377517 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which radiosurgical hypophysectomy is the first listed.

NCT03377517 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03377517 about?

NCT03377517 is a clinical study titled "Radiosurgical Hypophysectomy for Bone Metasteses Pain". This research is being done to see if a delivery of a single high dose of radiation therapy to a small area of the pituitary gland and pituitary stalk in a highly precise manner may be helpful in reducing intractable pain from bone metastases.

What is the current status of trial NCT03377517?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-05-08. Estimated completion is 2024-05-15.

What interventions are being tested in trial NCT03377517?

The interventions under investigation include: radiosurgical hypophysectomy (RADIATION).

Who is sponsoring clinical trial NCT03377517?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.